Charles River Laboratories | CRL - Ordinary Share Capital


Charles River Laboratories reported $47.88M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Agilent USD 281.97M 252K Jun/2026
Align Technology USD 71.04M 578K Sep/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Cardinal Health USD 232M 1000K Sep/2026
Charles River Laboratories USD 47.88M 148K Sep/2026
Cigna USD 264.6M 1.14M Mar/2026
Concord Medical Services Hldg CNY 130.25M 0 Dec/2025
CVS Health USD 1.28B 2M Sep/2026
Danaher USD 703.4M 500K Sep/2026
Dentsply International USD 198.2M 1000K Sep/2026
Elevance Health USD 216.11M 727K Sep/2026
Humana USD 120.08M 18K Jun/2026
Illumina USD 151.3M 607K Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Intrexon USD 0 0 Jun/2024
IQVIA Holdings USD 164.8M 200K Sep/2026
Laboratory Of America USD 81.2M 300K Sep/2026
Lakefront Biotherapeutics EUR 65.66M 242K Jun/2026
Lonza CHF 68.64M 0 Dec/2025
McKesson USD 115M 1000K Sep/2026
Merck EUR 434.78M 0 Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Novartis USD 1.89B 12.09M Sep/2026
Pfizer USD 5.7B 1000K Sep/2026
Quest Diagnostics USD 110M 0 Sep/2026
Revvity USD 111.59M 43K Sep/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
United Therapeutics USD 42.38M 295K Sep/2026
UnitedHealth USD 897.59M 10.55M Sep/2026
Veradigm USD 106.07M 103.28M Dec/2022
Waters USD 98.19M 20K Jun/2026
West Pharmaceutical Services USD 70.4M 500K Jun/2026